Article Information
History
- November 21, 2022.
Article Versions
- Version 1 (October 1, 2021 - 18:47).
- Version 2 (October 6, 2021 - 10:13).
- Version 3 (October 8, 2021 - 16:13).
- You are viewing Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Eric Daoud1,2,
- Anne-Sophie Hamy1,3,
- Elise Dumas1,4,5,
- Lidia Delrieu1,
- Beatriz Grandal Rejo1,6,
- Christine Le Bihan-Benjamin7,
- Sophie Houzard7,
- Philippe-Jean Bousquet8,9,
- Judicaël Hotton10,
- Aude-Marie Savoye11,
- Christelle Jouannaud11,
- Chloé-Agathe Azencott4,5,12,
- Marc Lelarge2 and
- Fabien Reyal1,6,10,*
- 1Residual Tumor & Response to Treatment Laboratory, RT2Lab, INSERM, U932 Immunity and Cancer, Institut Curie, Université Paris, 75005 Paris, France
- 2INRIA, DI/ENS, PSL Research University, Paris, France
- 3Department of Medical Oncology, Institut Curie, Paris, France
- 4INSERM, U900, 75005 Paris, France
- 5MINES ParisTech, PSL Research University, CBIO-Centre for Computational Biology, 75006 Paris, France
- 6Department of Surgery, Institut Curie, Paris, France
- 7Health Data and Assessment Department, Survey Data Science and Assessment Division, National Cancer Institute, 52 avenue André Morizet 92100 Boulogne-Billancourt, France
- 8Aix Marseille Univ, Inserm, IRD, SESSTIM, Equipe Labellisée Ligue Contre le Cancer, Marseille, France
- 9Survey Data Science and Assessment Division, National Cancer Institute, 52 avenue André Morizet 92100 Boulogne-Billancourt, France
- 10Department of Surgery, Institut Jean Godinot, Reims, France
- 11Department of Medical Oncology, Institut Jean Godinot, Reims, France
- 12Institut Curie, PSL Research University, 75005 Paris, France
- ↵*Corresponding Author: Fabien Reyal, Institut Curie, 26 rue d’Ulm, Paris 75005, France. Phone: + 33(0)142346339; E-mail: fabien.reyal{at}curie.fr.